Filing Details

Accession Number:
0000950170-24-014537
Form Type:
5
Zero Holdings:
No
Publication Time:
2024-02-13 16:05:15
Reporting Period:
2023-12-31
Accepted Time:
2024-02-13 16:05:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1855608 Hannah Valantine C/O Bridgebio Pharma, Inc.
3160 Porter Dr., Suite 250
Palo Alto CA 94304
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-28 1,891 $13.18 1,891 No 5 P Indirect By Spouse
Common Stock Acquisiton 2021-12-28 1,542 $12.68 3,433 No 5 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Indirect By Spouse
No 5 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,764 Direct